As part of the ongoing process to prepare and respond to the coronavirus outbreak, the FDA has decided to collaborate with various global regulators, interagency partners, and product developers. The FDA will be collaborating with various healthcare experts and global regulators to counteract the coronavirus outbreak. This collaboration is aimed to expedite the development and availability of medical products essential to diagnose, treat, and prevent infection.
The FDA is also sharing updates to help developers understand the pathways, including emergency use authorization, that can rapidly advance and make medical countermeasures available for this virus. In addition to this, the FDA has also launched a landing page that provides key information for the public and medical stakeholders. Source:…
